ResearcherYokohama City UniversityNo recent work listed
Nobuhiro Tsuchiya
Matched on ORCID iD 0000-0003-1658-3936; OpenAlex author ID A5031024549. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2019: 2 papers · 2020: 1 paper
Papers 3
- Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy. Co-author DOI 10.1007/s00268-020-05503-4↗
- Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Fo… Co-author DOI 10.1007/s00268-019-05159-9↗
- Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative R… Co-author DOI 10.21873/anticanres.13615↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Takashi Murakami · 3 shared papers, 2019–2020 · strength 0.33
- Paper Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy. DOI 10.1007/s00268-020-05503-4↗
- Paper Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuva… DOI 10.21873/anticanres.13615↗
- Paper Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treat… DOI 10.1007/s00268-019-05159-9↗
- Yasuhiro Yabushita · 3 shared papers, 2019–2020 · strength 0.33
- Paper Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy. DOI 10.1007/s00268-020-05503-4↗
- Paper Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuva… DOI 10.21873/anticanres.13615↗
- Paper Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treat… DOI 10.1007/s00268-019-05159-9↗
- Itaru Endo · 3 shared papers, 2019–2020 · strength 0.33
- Paper Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy. DOI 10.1007/s00268-020-05503-4↗
- Paper Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuva… DOI 10.21873/anticanres.13615↗
- Paper Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treat… DOI 10.1007/s00268-019-05159-9↗
- Yuki Homma · 1 shared paper, 2019 · strength 0.10
- Hirokazu Kubo · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.